Transpulmonary Gradient After Cardiac Surgery Under Cardiopulmonary Bypass

NCT01723930 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2012-11-08

No results posted yet for this study

Summary

Get a better understanding of the pathophysiological processes of acute respiratory failure following cardiopulmonary bypass to initiate timely therapies targeted on a cell line.

Demonstrate that there is a relationship between increased transpulmonary gradients of inflammation biomarkers (sRAGE, sICAM-1, SPB, PAI-1, ROS) and pulmonary vascular resistance on the one hand and alveolo-capillary gas exchange on the other hand after cardiac surgery under cardiopulmonary bypass.

Conditions

  • Acute Respiratory Distress Syndrome After Cardiac Surgery Under Cardiopulmonary Bypass

Sponsors & Collaborators

  • University Hospital, Strasbourg, France

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01723930 on ClinicalTrials.gov